(Q48490305)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644589%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Discrepancies in the P-glycoprotein-mediated transport of (18)F-MPPF: a pharmacokinetic study in mice and non-human primates (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644589%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644589%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Wadad Saba

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644589%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Nicolas Tournier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644589%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Jean-Michel Scherrmann

6

object named as

Jean-Michel Scherrmann

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644589%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Marie-Anne Peyronneau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644589%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Sébastien Goutal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644589%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Frédéric Dolle

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644589%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Michel Bottlaender

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644589%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Héric Valette

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644589%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

30 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644589%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

published in

Pharmaceutical Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644589%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644589%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644589%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

2468-2476

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644589%20AND%20SRC:MED&resulttype=core&format=json

Transporters in absorption, distribution, and elimination

2 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

PET radiotracers: crossing the blood-brain barrier and surviving metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

Structure and function of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

Opioid transport by ATP-binding cassette transporters at the blood-brain barrier: implications for neuropsychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

Blood-brain barrier P-glycoprotein function in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

Avoiding barriers to PET radioligand development: cellular assays of brain efflux transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

Membrane transporters in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

In vivo kinetics of [F-18]MEFWAY: a comparison with [C-11]WAY100635 and [F-18]MPPF in the nonhuman primate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

Cyclosporine, a P-glycoprotein modulator, increases [18F]MPPF uptake in rat brain and peripheral tissues: microPET and ex vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

Imaging of P-glycoprotein-mediated pharmacoresistance in the hippocampus: proof-of-concept in a chronic rat model of temporal lobe epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

Positron emission tomography studies on binding of central nervous system drugs and P-glycoprotein function in the rodent brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

Transport of selected PET radiotracers by human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2): an in vitro screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

Establishment and characterization of the transformants stably-expressing MDR1 derived from various animal species in LLC-PK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

High-yield radiosynthesis and preliminary in vivo evaluation of p-[18F]MPPF, a fluoro analog of WAY-100635.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

18F-ZW-104: a new radioligand for imaging neuronal nicotinic acetylcholine receptors--in vitro binding properties and PET studies in baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

Several major antiepileptic drugs are substrates for human P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

In situ mouse carotid perfusion model: glucose and cholesterol transport in the eye and brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

[18F]MPPF as a tool for the in vivo imaging of 5-HT1A receptors in animal and human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

Simultaneous PET imaging of P-glycoprotein inhibition in multiple tissues in the pregnant nonhuman primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

Liquid chromatography-tandem mass spectrometry identification of metabolites of three phenylcarboxyl derivatives of the 5-HT(1A) antagonist, N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridyl) trans-4-fluorocyclohexanecarboxamide (FCWAY), p

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

Brain uptake of the acid metabolites of F-18-labeled WAY 100635 analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

Development of fluorine-18-labeled 5-HT1A antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

Modeling [18 F]MPPF positron emission tomography kinetics for the determination of 5-hydroxytryptamine(1A) receptor concentration with multiinjection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

Role of site-specific binding to plasma albumin in drug availability to brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

Effect of a P-glycoprotein inhibitor, Cyclosporin A, on the disposition in rodent brain and blood of the 5-HT1A receptor radioligand, [11C](R)-(-)-RWAY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

Quantification of serotonin 5-HT1A receptors in monkey brain with [11C](R)-(-)-RWAY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

11C-loperamide and its N-desmethyl radiometabolite are avid substrates for brain permeability-glycoprotein efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0776-7

In vivo evaluation of P-glycoprotein modulation of 8 PET radioligands used clinically.

21 January 2018

1 reference

12 December 2020

Overcoming Multidrug Resistance in Cancer: An Update on the Clinical Strategy of Inhibiting P-Glycoprotein

1 reference

12 December 2020

Tissue distribution, autoradiography, and metabolism of 4-(2'-methoxyphenyl)-1-[2' -[N-2"-pyridinyl)-p-[(18)F]fluorobenzamido]ethyl]piperazine (p-[(18)F]MPPF), a new serotonin 5-HT(1A) antagonist for positron emission tomography: An In vivo study in

1 reference

12 December 2020

Effect of cyclosporin A on protein binding of teniposide in cancer patients

1 reference

12 December 2020

Cerebral expression of drug transporters in epilepsy

1 reference

12 December 2020

In vivo delineation of 5-HT1A receptors in human brain with [18F]MPPF

1 reference

12 December 2020

Influence of P-glycoprotein on brain uptake of [18F]MPPF in rats

1 reference

12 December 2020

Substrate- and species-dependent inhibition of P-glycoprotein-mediated transport: implications for predicting in vivo drug interactions

1 reference

12 December 2020

On the quantification of [18F]MPPF binding to 5-HT1A receptors in the human brain

1 reference

12 December 2020

10.1007/S11095-012-0776-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22644589%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference